Demae-Can Co.,Ltd
Demae-Can Co.,Ltd (2484.T) Financial Performance & Income Statement Overview
Analyze Demae-Can Co.,Ltd (2484.T) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Demae-Can Co.,Ltd (2484.T) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Demae-Can Co.,Ltd 2484.T financial performance.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $9.82B | $11.05B | $12.30B | $12.56B |
| Cost of Revenue | $8.70B | $7.94B | $9.17B | $9.12B |
| Gross Profit | $1.13B | $3.11B | $3.13B | $3.44B |
| Gross Profit Ratio | $0.11 | $0.28 | $0.25 | $0.27 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $2.01B | $3.51B | $3.92B | $4.25B |
| Operating Expenses | $2.01B | $3.51B | $3.92B | $4.25B |
| Total Costs & Expenses | $10.71B | $11.45B | $13.09B | $13.37B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $401.00M | $2.04B | $805.00M |
| EBITDA | -$876.00M | $0.00 | $1.25B | $59.00M |
| EBITDA Ratio | -$0.09 | $0.00 | $0.10 | $0.005 |
| Operating Income | -$885.00M | -$400.00M | -$793.00M | -$805.00M |
| Operating Income Ratio | -$0.09 | -$0.04 | -$0.06 | -$0.06 |
| Other Income/Expenses (Net) | $9.00M | -$62.00M | $2.04B | $59.00M |
| Income Before Tax | -$876.00M | -$462.00M | $1.25B | -$746.00M |
| Income Before Tax Ratio | -$0.09 | -$0.04 | $0.10 | -$0.06 |
| Income Tax Expense | $3.00M | $3.00M | -$90.00M | $60.00M |
| Net Income | -$879.00M | -$465.00M | $1.34B | -$806.00M |
| Net Income Ratio | -$0.09 | -$0.04 | $0.11 | -$0.06 |
| EPS | -$7.68 | -$3.88 | $10.20 | -$6.10 |
| Diluted EPS | -$7.68 | -$3.88 | $10.20 | -$6.10 |
| Weighted Avg Shares Outstanding | $114.50M | $119.97M | $131.47M | $132.13M |
| Weighted Avg Shares Outstanding (Diluted) | $114.50M | $119.97M | $131.47M | $132.13M |
Over the last four quarters, Demae-Can Co.,Ltd's revenue moved from $12.56B in Q3 2024 to $9.82B in Q2 2025. Operating income in Q2 2025 was -$885.00M, with a strong operating margin of -9%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Demae-Can Co.,Ltd remained robust at -$876.00M, reflecting operational efficiency. Net income dropped to -$879.00M, with an EPS of -$7.68. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan